title: Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.
abstract: Cyclooxygenase-2 (COX-2) knockout (KO) mice in inbred strains can have renal dysfunction with secondary hyperparathyroidism (HPTH), making direct effects of COX-2 KO on bone difficult to assess. COX-2 KO mice in an outbred CD-1 background did not have renal dysfunction but still had two-fold elevated PTH compared to wild type (WT) mice. Compared to WT mice, KO mice had increased serum markers of bone turnover, decreased femoral bone mineral density (BMD) and cortical bone thickness, but no differences in trabecular bone volume by microCT or dynamic histomorphometry. Because PTH is a potent inducer of COX-2 and prostaglandin (PG) production, we examined the effects of COX-2 KO on bone responses after 3 weeks of intermittent PTH. Intermittent PTH increased femoral BMD and cortical bone area more in KO mice than in WT mice and increased trabecular bone volume in the distal femur in both WT and KO mice. Although not statistically significant, PTH-stimulated increases in trabecular bone tended to be greater in KO mice than in WT mice. PTH increased serum markers of bone formation and resorption more in KO than in WT mice but increased the ratio of osteoblastic surface-to-osteoclastic surface only in KO mice. PTH also increased femoral mineral apposition rates and bone formation rates in KO mice more than in WT mice. Acute mRNA responses to PTH of genes that might mediate some anabolic and catabolic effects of PTH tended to be greater in KO than WT mice. We conclude that (1) the basal bone phenotype in male COX-2 KO mice might reflect HPTH, COX-2 deficiency or both, and (2) increased responses to intermittent PTH in COX-2 KO mice, despite the presence of chronic HPTH, suggest that absence of COX-2 increased sensitivity to PTH. It is possible that manipulation of endogenous PGs could have important clinical implications for anabolic therapy with PTH.
authors.affiliation: Department of Medicine, University of Connecticut Health Center, Farmington, CT 06030, USA.
authors.forename: Manshan
authors.initials: M
authors.lastname: Xu
authors.forename: Shilpa
authors.initials: S
authors.lastname: Choudhary
authors.forename: Olga
authors.initials: O
authors.lastname: Voznesensky
authors.forename: Qi
authors.initials: Q
authors.lastname: Gao
authors.forename: Douglas
authors.initials: D
authors.lastname: Adams
authors.forename: Vilmaris
authors.initials: V
authors.lastname: Diaz-Doran
authors.forename: Qian
authors.initials: Q
authors.lastname: Wu
authors.forename: David
authors.initials: D
authors.lastname: Goltzman
authors.forename: Lawrence G
authors.initials: LG
authors.lastname: Raisz
authors.forename: Carol C
authors.initials: CC
authors.lastname: Pilbeam
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000097:blood; D001835:Body Weight / Q000187:drug effects; D016723:Bone Remodeling / Q000187:drug effects; D051545:Cyclooxygenase 1 / Q000235:genetics / Q000378:metabolism; D051546:Cyclooxygenase 2 / Q000172:deficiency* / Q000378:metabolism; D005269:Femur / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology*; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects; D006262:Health; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000235:genetics / Q000503:physiopathology; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D008297:Male; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D009929:Organ Size / Q000187:drug effects; D053244:Osteoprotegerin / Q000235:genetics / Q000378:metabolism; D010281:Parathyroid Hormone / Q000494:pharmacology*; D010641:Phenotype; D053245:RANK Ligand / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011859:Radiography
chemical_list: D015415:Biomarkers; D008565:Membrane Proteins; D053244:Osteoprotegerin; D010281:Parathyroid Hormone; D053245:RANK Ligand; D012333:RNA, Messenger; C077623:Ptgs2 protein, mouse; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; C496512:Ptgs1 protein, mouse
references.citation: J Bone Miner Res. 2005 Oct;20(10):1888-98
references.pmid: 16355502
references.citation: Bone. 1997 Jun;20(6):521-6
references.pmid: 9177865
references.citation: Endocrinology. 2005 Nov;146(11):4577-83
references.pmid: 16081646
references.citation: Endocrinology. 1992 Jan;130(1):443-8
references.pmid: 1309342
references.citation: Kidney Int. 2000 Dec;58(6):2291-300
references.pmid: 11115063
references.citation: J Bone Joint Surg Am. 2007 Mar;89(3):500-11
references.pmid: 17332098
references.citation: J Bone Miner Res. 1990 Oct;5(10):1063-7
references.pmid: 2080717
references.citation: Calcif Tissue Int. 2003 Oct;73(4):387-92
references.pmid: 12874706
references.citation: J Bone Miner Res. 1992 Dec;7 Suppl 2:S369-75
references.pmid: 1485545
references.citation: Bone. 2002 Jul;31(1):252-9
references.pmid: 12110442
references.citation: J Biol Chem. 2004 Mar 12;279(11):10649-58
references.pmid: 14701858
references.citation: Endocrinology. 1997 Sep;138(9):3594-600
references.pmid: 9275040
references.citation: J Clin Endocrinol Metab. 2007 Aug;92(8):3001-5
references.pmid: 17536001
references.citation: J Bone Joint Surg Am. 2004 Jan;86(1):116-23
references.pmid: 14711953
references.citation: Nature. 2007 Jun 21;447(7147):1007-11
references.pmid: 17581586
references.citation: Calcif Tissue Int. 1989 Jul;45(1):34-40
references.pmid: 2504461
references.citation: Endocrinology. 1981 Nov;109(5):1545-51
references.pmid: 6271534
references.citation: Cell. 1997 Oct 17;91(2):197-208
references.pmid: 9346237
references.citation: J Bone Miner Res. 2003 Oct;18(10):1813-24
references.pmid: 14584892
references.citation: Pediatr Pathol Lab Med. 1996 May-Jun;16(3):489-507
references.pmid: 9025848
references.citation: Endocrinology. 1996 Dec;137(12):5435-40
references.pmid: 8940368
references.citation: J Bone Miner Res. 2002 Jun;17(6):963-76
references.pmid: 12054171
references.citation: Biochem Biophys Res Commun. 1998 May 19;246(2):337-41
references.pmid: 9610359
references.citation: J Musculoskelet Neuronal Interact. 2006 Oct-Dec;6(4):358-9
references.pmid: 17185824
references.citation: J Bone Miner Res. 2007 Jul;22(7):1002-10
references.pmid: 17371157
references.citation: J Bone Miner Res. 2005 Mar;20(3):438-46
references.pmid: 15746988
references.citation: Bone. 2006 Oct;39(4):767-72
references.pmid: 16731065
references.citation: J Cell Biochem. 1999 Apr 1;73(1):36-48
references.pmid: 10088722
references.citation: Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:95-114
references.pmid: 12432912
references.citation: Biochem Biophys Res Commun. 2008 Aug 8;372(4):536-41
references.pmid: 18501188
references.citation: J Endocrinol. 1998 Jan;156(1):51-7
references.pmid: 9496233
references.citation: J Clin Invest. 2000 Mar;105(6):823-32
references.pmid: 10727451
references.citation: J Bone Miner Res. 2002 Aug;17(8):1430-40
references.pmid: 12162497
references.citation: Cell. 1995 Nov 3;83(3):473-82
references.pmid: 8521477
references.citation: Endocrinology. 1997 Dec;138(12):5427-33
references.pmid: 9389528
references.citation: J Bone Joint Surg Am. 2007 Jan;89(1):114-25
references.pmid: 17200318
references.citation: Bone. 2007 Jun;40(6):1453-61
references.pmid: 17376756
references.citation: Cytokine Growth Factor Rev. 2006 Jun;17(3):203-16
references.pmid: 16460988
references.citation: Annu Rev Biochem. 2000;69:145-82
references.pmid: 10966456
references.citation: Endocr Pathol. 2004 Spring;15(1):29-38
references.pmid: 15067174
references.citation: Endocrinology. 2005 Apr;146(4):1843-53
references.pmid: 15625247
references.citation: J Clin Endocrinol Metab. 2003 Oct;88(10):4641-8
references.pmid: 14557434
references.citation: J Pediatr. 1980 Nov;97(5):834-6
references.pmid: 7000997
references.citation: J Bone Miner Res. 1987 Dec;2(6):595-610
references.pmid: 3455637
references.citation: Bone. 2002 Apr;30(4):567-73
references.pmid: 11934647
references.citation: Bone. 2006 Nov;39(5):1048-1052
references.pmid: 16875891
references.citation: J Bone Miner Res. 2002 Sep;17(9):1570-8
references.pmid: 12211426
references.citation: Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1059-64
references.pmid: 11158594
references.citation: Am J Physiol. 1994 Aug;267(2 Pt 1):E287-92
references.pmid: 8074209
references.citation: Bone. 1994 Sep-Oct;15(5):489-96
references.pmid: 7980959
references.citation: Pharmacol Res. 1990 Jan-Feb;22(1):59-70
references.pmid: 2330339
references.citation: Endocrinology. 1970 Jun;86(6):1436-40
references.pmid: 4315103
references.citation: Cancer Metastasis Rev. 1994 Dec;13(3-4):241-56
references.pmid: 7712587
references.citation: Bone. 2003 May;32(5):513-20
references.pmid: 12753867
references.citation: Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4580-5
references.pmid: 11917107
references.citation: Prostaglandins. 1985 Jan;29(1):35-46
references.pmid: 3883430
references.citation: Arthritis Res Ther. 2003;5(1):5-7
references.pmid: 12716441
references.citation: Clin Pharmacol Ther. 2001 Oct;70(4):384-90
references.pmid: 11673754
references.citation: Bone. 1997 Oct;21(4):297-304
references.pmid: 9315332
references.citation: Bone. 2007 Jul;41(1):68-76
references.pmid: 17467356
references.citation: Bone. 2005 Aug;37(2):148-58
references.pmid: 15946907
references.citation: J Biol Chem. 1995 Sep 22;270(38):22378-85
references.pmid: 7673223
references.citation: J Immunol. 2004 Feb 15;172(4):2504-10
references.pmid: 14764723
references.citation: J Bone Miner Res. 1995 Mar;10(3):474-87
references.pmid: 7785470
references.citation: Calcif Tissue Int. 2005 Aug;77(2):96-103
references.pmid: 16075364
references.citation: Endocrinology. 2008 Apr;149(4):1728-35
references.pmid: 18187554
references.citation: Ann N Y Acad Sci. 2006 Apr;1068:458-70
references.pmid: 16831943
references.citation: Calcif Tissue Int. 1988 Jun;42(6):363-8
references.pmid: 3135105
references.citation: J Clin Invest. 2002 Jun;109(11):1405-15
references.pmid: 12045254
references.citation: J Clin Invest. 2001 May;107(9):1093-102
references.pmid: 11342573
references.citation: J Pharmacol Sci. 2005 Nov;99(3):272-6
references.pmid: 16293937